Ildong seeks sales boost of 3 flagship products

Published: 2009-05-22 06:56:00

Updated: 2009-05-22 06:56:00

Ildong Pham unveiled its plan to beep up the marketing activities of its three leading products, including Samion and Curan , to achieve a 90 billion-won in combined sales.

Samion (nicergolin), cerebrovascular medicine, has fared well thanks to the company’s intensive marketing campaigns. Sami...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK